UCLA scientists uncover mechanism for melanoma drug resistance
UCLA researchers have uncovered how an advanced form of melanoma gets around an inhibitor, Zelboraf, which targets the BRAF gene, a gene that is mutated in some metastatic melanoma. In some patients...
View ArticleNew chemical target for inflammation treatment
Researchers from The Scripps Research Institute recently conducted a study in which they discovered new chemical compounds that inhibit an enzyme called PRMT1 (protein arginine methyltransferase 1)...
View Article
More Pages to Explore .....
